Biogipuzkoa
Centro de investigación
![Foto de Biogipuzkoa](/img/uploaded/BB680065D0326B877226AAACFBE7F51A.png)
![Foto de VU University Amsterdam](/img/noimage_org.png)
VU University Amsterdam
Ámsterdam, HolandaPublicaciones en colaboración con investigadores/as de VU University Amsterdam (55)
2024
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia
Human Brain Mapping, Vol. 44, Núm. 7, pp. 2684-2700
-
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology
Alzheimer's and Dementia, Vol. 19, Núm. 3, pp. 807-820
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
-
Genetic Associations between Modifiable Risk Factors and Alzheimer Disease
JAMA Network Open, Vol. 6, Núm. 5
-
Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes
Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 36
-
Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease
Alzheimer's and Dementia, Vol. 19, Núm. 8, pp. 3350-3364
-
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Genome Medicine, Vol. 15, Núm. 1
2022
-
Association of Rare APOE Missense Variants V236E and R251G with Risk of Alzheimer Disease
JAMA Neurology, Vol. 79, Núm. 7, pp. 652-663
-
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease
Molecular neurodegeneration, Vol. 17, Núm. 1, pp. 27
-
Childhood adversities and suicidal thoughts and behaviors among first-year college students: results from the WMH-ICS initiative
Social Psychiatry and Psychiatric Epidemiology, Vol. 57, Núm. 8, pp. 1591-1601
-
Concerted alterations of functional connectivity and WM integrity in relationship to early amyloid deposition
Alzheimer's and Dementia
-
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease (Molecular Neurodegeneration, (2022), 17, 1, (27), 10.1186/s13024-022-00521-3)
Molecular Neurodegeneration
-
Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 14, Núm. 1
-
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study
Journal of neuroinflammation, Vol. 19, Núm. 1, pp. 217
-
Functional eigenvector centrality dynamics are related to amyloid deposition in preclinical Alzheimer’s Disease
Alzheimer's and Dementia
-
Functional eigenvector centrality dynamics are related to amyloid deposition in preclinical Alzheimer’s Disease
Alzheimer's and Dementia
-
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842